Na, just treat them in proportion to their degree of market importance. If you take out Hybrids, EVS make up less than 1% of the total market but get 99% coverage on these pathetic threads! Who's promoting their hip pockets here?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025